Menopausal hormone therapy and the risk of cataracts in postmenopausal women in South Korea.
Jin-Sung YukJae Yong ParkHa Eun SimJe Hyung HwangPublished in: Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians (Optometrists) (2023)
Women undergoing post-MHT, including tibolone, had a higher incidence of cataracts. Cataract development should be a concern when examining postmenopausal patients using MHT.
Keyphrases
- postmenopausal women
- bone mineral density
- end stage renal disease
- newly diagnosed
- ejection fraction
- chronic kidney disease
- prognostic factors
- risk factors
- type diabetes
- polycystic ovary syndrome
- stem cells
- patient reported outcomes
- metabolic syndrome
- skeletal muscle
- mesenchymal stem cells
- cell therapy
- patient reported
- pregnancy outcomes